Tower Research Capital (TRC)’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
Tower Research Capital (TRC)'s BTEC Position: Q3 2024 in Review
Tower Research Capital (TRC) sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 3 shares — an estimated $109 sold.
Tower Research Capital (TRC) first reported a position in BTEC in Q4 2019 and held it in 11 quarters. The position peaked at $8K in Q4 2021. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.
- Tower Research Capital (TRC) reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 3 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $109.
- Tower Research Capital (TRC) first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q4 2019 and held it in 11 quarters.
- Tower Research Capital (TRC)'s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $8K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.